Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Novartis Ag ADR (NVS)

Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Novartis Ag (NVS) Q2 2024 Earnings Call Transcript

NVS earnings call for the period ending June 30, 2024.

NVS : 110.32 (+0.35%)
Why Novartis Stock Is Down Today Despite Topping Q2 Estimates

Investors were caught off guard by a decision on the research and development front.

NVS : 110.32 (+0.35%)
2 Magnificent Stocks to Buy With $500

These reliable healthcare companies look attractive no matter how you slice it.

MRK : 125.26 (-0.47%)
NVS : 110.32 (+0.35%)
Wholesale Trade, Housing Starts Next Week

Monday U.S. Featured Earnings Goldman Sachs Group Inc. (NYSE:GS) (Q2) EPS of $8.70, compared ...

CJR-B.TO : 0.1050 (unch)
GS.TO : 14.24 (-0.07%)
PTM.TO : 2.26 (-0.44%)
PSK.TO : 27.80 (+1.61%)
GS : 499.03 (+1.49%)
HDB : 60.64 (+0.73%)
BLK : 856.20 (+2.35%)
UNH : 569.72 (+1.79%)
BAC : 41.67 (-0.02%)
MS : 104.19 (+0.61%)
ASML : 888.39 (+2.99%)
JNJ : 160.64 (+0.63%)
Novartis Canada launches $500,000 funding initiative to improve health equity in Canada

/CNW/ - Novartis Pharmaceuticals Canada Inc. (Novartis) today announced the launch of a new health equity initiative, aimed at addressing health disparities...

NVS : 110.32 (+0.35%)
The Novartis Oncology Young Canadian Investigator Awards (NOYCIA) returns for its 21st year at ASCO 2024

/CNW/ - Novartis Canada is pleased to announce the winners of the 2024 Novartis Oncology Young Canadian Investigator Awards (NOYCIA), an annual national...

NVS : 110.32 (+0.35%)
NOVARTIS CANADA AND CLARIUS MOBILE HEALTH CHALLENGE STANDARD OF CARE FOR PSORIATIC ARTHRITIS WITH NEW PARTNERSHIP

Psoriatic arthritis is a chronic, autoimmune disease form of arthritis that causes joint inflammation (swelling, pain, stiffness) and occurs with skin...

NVS : 110.32 (+0.35%)
AAPL : 217.96 (+0.22%)
Health Canada approves Cosentyx®, a biologic therapy, for the treatment of adults with moderate to severe Hidradenitis Suppurativa (HS)

/CNW/ - Novartis Pharmaceuticals Canada Inc. (Novartis) is pleased to announce that Health Canada has granted Cosentyx® (secukinumab) with a Notice of...

NVS : 110.32 (+0.35%)
3 Magnificent Stocks That Are Passive Income Machines

These three companies have track records that should please investors.

LLY : 804.62 (-2.02%)
ABBV : 185.16 (+1.64%)
NVS : 110.32 (+0.35%)
2 Magnificent Dividend Stocks to Hold for the Next Decade

The dividend is just one reason to buy these stocks.

NVS : 110.32 (+0.35%)
V : 259.46 (+2.25%)

Barchart Exclusives

3 High Dividend Stocks Beginning To Breakout Off Their 52-Week Lows
These stocks have recently hit their 52-week lows and are highly rated. Is now the time to buy? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar